Title : Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation.

Pub. Date : 2019 Nov

PMID : 31492693






10 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
2 The goal of this study was to determine the effect of CYP3A5 genotype and individual variation in CYP3A activity on the metabolic activation of lapatinib using human-relevant in vitro systems. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
3 Further, the relative contributions of CYP3A4 and CYP3A5 to lapatinib O-debenzylation were estimated using selective chemical inhibitors of CYP3A. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
4 Further, the relative contributions of CYP3A4 and CYP3A5 to lapatinib O-debenzylation were estimated using selective chemical inhibitors of CYP3A. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
5 The results from this study demonstrated that lapatinib O-debenzylation and quinone imine-GSH conjugate formation were highly correlated with hepatic CYP3A activity, as measured by midazolam 1"-hydroxylation. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
6 CYP3A4 played a dominant role in lapatinib bioactivation in all liver tissues evaluated. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
7 These findings indicate that individual CYP3A activity, not CYP3A5 genotype alone, is a key determinant of lapatinib bioactivation and likely influences exposure to reactive metabolites. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
8 SIGNIFICANCE STATEMENT: This study is the first to examine the effect of CYP3A5 genotype, total CYP3A activity, and CYP3A5-selective activity on lapatinib bioactivation in individual human liver tissues. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
9 The results of this investigation indicate that lapatinib bioactivation via oxidative O-debenzylation is highly correlated with total hepatic CYP3A activity, and not CYP3A5 genotype alone. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens
10 These findings provide insight into the individual factors, namely, CYP3A activity, that may affect individual exposure to reactive, potentially toxic metabolites of lapatinib. Lapatinib cytochrome P450 family 3 subfamily A member 4 Homo sapiens